These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 22795285

  • 1. The electrocardiographic features associated with cardiac amyloidosis of variant transthyretin isoleucine 122 type in Afro-Caribbean patients.
    Dungu J, Sattianayagam PT, Whelan CJ, Gibbs SD, Pinney JH, Banypersad SM, Rowczenio D, Gilbertson JA, Lachmann HJ, Wechalekar A, Gillmore JD, Hawkins PN, Anderson LJ.
    Am Heart J; 2012 Jul; 164(1):72-9. PubMed ID: 22795285
    [Abstract] [Full Text] [Related]

  • 2. Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model.
    Arvanitis M, Koch CM, Chan GG, Torres-Arancivia C, LaValley MP, Jacobson DR, Berk JL, Connors LH, Ruberg FL.
    JAMA Cardiol; 2017 Mar 01; 2(3):305-313. PubMed ID: 28196196
    [Abstract] [Full Text] [Related]

  • 3. Afro-Caribbean Heart Failure in the United Kingdom: Cause, Outcomes, and ATTR V122I Cardiac Amyloidosis.
    Dungu JN, Papadopoulou SA, Wykes K, Mahmood I, Marshall J, Valencia O, Fontana M, Whelan CJ, Gillmore JD, Hawkins PN, Anderson LJ.
    Circ Heart Fail; 2016 Sep 01; 9(9):. PubMed ID: 27618855
    [Abstract] [Full Text] [Related]

  • 4. Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis.
    Connors LH, Prokaeva T, Lim A, Théberge R, Falk RH, Doros G, Berg A, Costello CE, O'Hara C, Seldin DC, Skinner M.
    Am Heart J; 2009 Oct 01; 158(4):607-14. PubMed ID: 19781421
    [Abstract] [Full Text] [Related]

  • 5. Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS).
    Bhuiyan T, Helmke S, Patel AR, Ruberg FL, Packman J, Cheung K, Grogan D, Maurer MS.
    Circ Heart Fail; 2011 Mar 01; 4(2):121-8. PubMed ID: 21191093
    [Abstract] [Full Text] [Related]

  • 6. Clinical Penetrance of the Transthyretin V122I Variant in Older Black Patients With Heart Failure: The SCAN-MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study.
    Madhani A, Sabogal N, Massillon D, Paul LD, Rodriguez C, Fine D, Helmke S, Winburn M, Kurian D, Raiszadeh F, Teruya S, Cohn E, Einstein AJ, Miller EJ, Connors LH, Maurer MS, Ruberg FL.
    J Am Heart Assoc; 2023 Aug 01; 12(15):e028973. PubMed ID: 37486082
    [Abstract] [Full Text] [Related]

  • 7. Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS).
    Ruberg FL, Maurer MS, Judge DP, Zeldenrust S, Skinner M, Kim AY, Falk RH, Cheung KN, Patel AR, Pano A, Packman J, Grogan DR.
    Am Heart J; 2012 Aug 01; 164(2):222-228.e1. PubMed ID: 22877808
    [Abstract] [Full Text] [Related]

  • 8. Cardiac transthyretin amyloidosis.
    Dungu JN, Anderson LJ, Whelan CJ, Hawkins PN.
    Heart; 2012 Nov 01; 98(21):1546-54. PubMed ID: 22888163
    [Abstract] [Full Text] [Related]

  • 9. Race, Genotype, and Prognosis in Black Patients With Transthyretin Cardiac Amyloidosis.
    Khedraki R, Saef J, Martens P, Martyn T, Sul L, Hachamovitch R, Ives L, Estep JD, Tang WHW, Hanna M.
    Am J Cardiol; 2024 Apr 01; 216():66-76. PubMed ID: 38278432
    [Abstract] [Full Text] [Related]

  • 10. Transthyretin Ile 122 and cardiac amyloidosis in African-Americans. 2 case reports.
    Jacobson DR, Ittmann M, Buxbaum JN, Wieczorek R, Gorevic PD.
    Tex Heart Inst J; 1997 Apr 01; 24(1):45-52. PubMed ID: 9068139
    [Abstract] [Full Text] [Related]

  • 11. Relation of clinical, echocardiographic and electrocardiographic features of cardiac amyloidosis to the presence of the transthyretin V122I allele in older African-American men.
    Jacobson D, Tagoe C, Schwartzbard A, Shah A, Koziol J, Buxbaum J.
    Am J Cardiol; 2011 Aug 01; 108(3):440-4. PubMed ID: 21600538
    [Abstract] [Full Text] [Related]

  • 12. Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy.
    Porcari A, Razvi Y, Masi A, Patel R, Ioannou A, Rauf MU, Hutt DF, Rowczenio D, Gilbertson J, Martinez-Naharro A, Venneri L, Whelan C, Lachmann H, Wechalekar A, Quarta CC, Merlo M, Sinagra G, Hawkins PN, Fontana M, Gillmore JD.
    Eur J Heart Fail; 2023 Apr 01; 25(4):515-524. PubMed ID: 36644836
    [Abstract] [Full Text] [Related]

  • 13. Clinical comparison of V122I genotypic variant of transthyretin amyloid cardiomyopathy with wild-type and other hereditary variants: a systematic review.
    Goyal A, Lahan S, Dalia T, Ranka S, Bhattad VB, Patel RR, Shah Z.
    Heart Fail Rev; 2022 May 01; 27(3):849-856. PubMed ID: 33768376
    [Abstract] [Full Text] [Related]

  • 14. Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry.
    Parker MM, Damrauer SM, Tcheandjieu C, Erbe D, Aldinc E, Hawkins PN, Gillmore JD, Hull LE, Lynch JA, Joseph J, Ticau S, Flynn-Carroll AO, Deaton AM, Ward LD, Assimes TL, Tsao PS, Chang KM, Rader DJ, Fitzgerald K, Vaishnaw AK, Hinkle G, Nioi P.
    Sci Rep; 2021 Jun 02; 11(1):11645. PubMed ID: 34079032
    [Abstract] [Full Text] [Related]

  • 15. The amyloidogenic V122I transthyretin variant in elderly black Americans.
    Quarta CC, Buxbaum JN, Shah AM, Falk RH, Claggett B, Kitzman DW, Mosley TH, Butler KR, Boerwinkle E, Solomon SD.
    N Engl J Med; 2015 Jan 01; 372(1):21-9. PubMed ID: 25551524
    [Abstract] [Full Text] [Related]

  • 16. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans.
    Jacobson DR, Pastore RD, Yaghoubian R, Kane I, Gallo G, Buck FS, Buxbaum JN.
    N Engl J Med; 1997 Feb 13; 336(7):466-73. PubMed ID: 9017939
    [Abstract] [Full Text] [Related]

  • 17. Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans.
    Buxbaum JN, Ruberg FL.
    Genet Med; 2017 Jul 13; 19(7):733-742. PubMed ID: 28102864
    [Abstract] [Full Text] [Related]

  • 18. Low Prevalence of Clinically Apparent Cardiac Amyloidosis Among Carriers of Transthyretin V122I Variant in a Large Electronic Medical Record.
    Agbor-Etang BB, Okafor HE, Farber-Eger EH, Wells QS.
    Am J Med; 2021 Feb 13; 134(2):e98-e100. PubMed ID: 32866461
    [Abstract] [Full Text] [Related]

  • 19. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.
    Nehashi T, Oikawa M, Amami K, Kanno Y, Yokokawa T, Misaka T, Yamada S, Kunii H, Nakazato K, Ishida T, Takeishi Y.
    Int Heart J; 2019 Nov 30; 60(6):1441-1443. PubMed ID: 31666456
    [Abstract] [Full Text] [Related]

  • 20. Comparison of cardiac involvement, extracardiac manifestations and outcomes between homozygote and heterozygote transthyretin p.Val142Ile (V122I) variant in patients with hereditary transthyretin amyloidosis: a cohort study.
    Albenque G, Bézard M, Kharoubi M, Odouard S, Lunati A, Poullot E, Zaroui A, Teiger E, Hittinger L, Audard V, El Karoui K, Funalot B, Fanen P, Damy T, Oghina S.
    Amyloid; 2023 Dec 30; 30(4):407-415. PubMed ID: 37377439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.